Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.81
EXAC's Cash to Debt is ranked lower than
69% of the 315 Companies
in the Global Medical Devices industry.

( Industry Median: 2.75 vs. EXAC: 0.81 )
Ranked among companies with meaningful Cash to Debt only.
EXAC' s Cash to Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.18 Max: No Debt
Current: 0.81
Equity to Asset 0.81
EXAC's Equity to Asset is ranked higher than
79% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. EXAC: 0.81 )
Ranked among companies with meaningful Equity to Asset only.
EXAC' s Equity to Asset Range Over the Past 10 Years
Min: 0.39  Med: 0.73 Max: 0.88
Current: 0.81
0.39
0.88
Interest Coverage 21.67
EXAC's Interest Coverage is ranked lower than
71% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: 261.39 vs. EXAC: 21.67 )
Ranked among companies with meaningful Interest Coverage only.
EXAC' s Interest Coverage Range Over the Past 10 Years
Min: 6.39  Med: 15.69 Max: 28.71
Current: 21.67
6.39
28.71
F-Score: 6
Z-Score: 5.59
M-Score: -2.50
WACC vs ROIC
10.45%
7.84%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.93
EXAC's Operating margin (%) is ranked higher than
72% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. EXAC: 9.93 )
Ranked among companies with meaningful Operating margin (%) only.
EXAC' s Operating margin (%) Range Over the Past 10 Years
Min: 6.73  Med: 10.34 Max: 13.6
Current: 9.93
6.73
13.6
Net-margin (%) 6.51
EXAC's Net-margin (%) is ranked higher than
66% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. EXAC: 6.51 )
Ranked among companies with meaningful Net-margin (%) only.
EXAC' s Net-margin (%) Range Over the Past 10 Years
Min: 4.3  Med: 6.56 Max: 7.57
Current: 6.51
4.3
7.57
ROE (%) 7.34
EXAC's ROE (%) is ranked higher than
61% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.51 vs. EXAC: 7.34 )
Ranked among companies with meaningful ROE (%) only.
EXAC' s ROE (%) Range Over the Past 10 Years
Min: 5.87  Med: 8.32 Max: 10.86
Current: 7.34
5.87
10.86
ROA (%) 5.87
EXAC's ROA (%) is ranked higher than
69% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 0.42 vs. EXAC: 5.87 )
Ranked among companies with meaningful ROA (%) only.
EXAC' s ROA (%) Range Over the Past 10 Years
Min: 3.9  Med: 6.19 Max: 7.81
Current: 5.87
3.9
7.81
ROC (Joel Greenblatt) (%) 12.29
EXAC's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. EXAC: 12.29 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
EXAC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 9.09  Med: 13.52 Max: 18.6
Current: 12.29
9.09
18.6
Revenue Growth (3Y)(%) 4.50
EXAC's Revenue Growth (3Y)(%) is ranked higher than
55% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. EXAC: 4.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
EXAC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 4.5  Med: 14.95 Max: 30.5
Current: 4.5
4.5
30.5
EBITDA Growth (3Y)(%) 10.50
EXAC's EBITDA Growth (3Y)(%) is ranked higher than
66% of the 182 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. EXAC: 10.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
EXAC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 2.4  Med: 12.45 Max: 38.1
Current: 10.5
2.4
38.1
EPS Growth (3Y)(%) 20.70
EXAC's EPS Growth (3Y)(%) is ranked higher than
73% of the 186 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. EXAC: 20.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
EXAC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -8.5  Med: 13.80 Max: 34.6
Current: 20.7
-8.5
34.6
» EXAC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

EXAC Guru Trades in Q1 2015

Jim Simons 46,900 sh (+6.11%)
Mario Gabelli 644,552 sh (+0.29%)
Chuck Royce 780,227 sh (-3.40%)
» More
Q2 2015

EXAC Guru Trades in Q2 2015

Jim Simons 53,700 sh (+14.50%)
Mario Gabelli 646,679 sh (+0.33%)
Chuck Royce 714,619 sh (-8.41%)
» More
Q3 2015

EXAC Guru Trades in Q3 2015

Jim Simons 66,500 sh (+23.84%)
Mario Gabelli 639,479 sh (-1.11%)
Chuck Royce 667,856 sh (-6.54%)
» More
Q4 2015

EXAC Guru Trades in Q4 2015

Mario Gabelli 649,279 sh (+1.53%)
Chuck Royce 596,546 sh (-10.68%)
» More
» Details

Insider Trades

Latest Guru Trades with EXAC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.07
EXAC's P/E(ttm) is ranked higher than
72% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 30.00 vs. EXAC: 17.07 )
Ranked among companies with meaningful P/E(ttm) only.
EXAC' s P/E(ttm) Range Over the Past 10 Years
Min: 13.61  Med: 21.75 Max: 34.81
Current: 17.07
13.61
34.81
Forward P/E 15.95
EXAC's Forward P/E is ranked higher than
66% of the 180 Companies
in the Global Medical Devices industry.

( Industry Median: 18.42 vs. EXAC: 15.95 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 17.07
EXAC's PE(NRI) is ranked higher than
71% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 28.80 vs. EXAC: 17.07 )
Ranked among companies with meaningful PE(NRI) only.
EXAC' s PE(NRI) Range Over the Past 10 Years
Min: 13.63  Med: 21.76 Max: 35
Current: 17.07
13.63
35
P/B 1.23
EXAC's P/B is ranked higher than
78% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. EXAC: 1.23 )
Ranked among companies with meaningful P/B only.
EXAC' s P/B Range Over the Past 10 Years
Min: 1.07  Med: 1.59 Max: 3.48
Current: 1.23
1.07
3.48
P/S 1.13
EXAC's P/S is ranked higher than
75% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. EXAC: 1.13 )
Ranked among companies with meaningful P/S only.
EXAC' s P/S Range Over the Past 10 Years
Min: 0.85  Med: 1.26 Max: 2.59
Current: 1.13
0.85
2.59
PFCF 26.38
EXAC's PFCF is ranked higher than
64% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 33.85 vs. EXAC: 26.38 )
Ranked among companies with meaningful PFCF only.
EXAC' s PFCF Range Over the Past 10 Years
Min: 14.45  Med: 32.46 Max: 353.86
Current: 26.38
14.45
353.86
POCF 9.23
EXAC's POCF is ranked higher than
88% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 21.54 vs. EXAC: 9.23 )
Ranked among companies with meaningful POCF only.
EXAC' s POCF Range Over the Past 10 Years
Min: 7.51  Med: 11.75 Max: 46.13
Current: 9.23
7.51
46.13
EV-to-EBIT 12.04
EXAC's EV-to-EBIT is ranked higher than
78% of the 267 Companies
in the Global Medical Devices industry.

( Industry Median: 21.98 vs. EXAC: 12.04 )
Ranked among companies with meaningful EV-to-EBIT only.
EXAC' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.2  Med: 14.50 Max: 21.6
Current: 12.04
9.2
21.6
EV-to-EBITDA 6.63
EXAC's EV-to-EBITDA is ranked higher than
87% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 16.86 vs. EXAC: 6.63 )
Ranked among companies with meaningful EV-to-EBITDA only.
EXAC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6  Med: 8.60 Max: 15
Current: 6.63
6
15
PEG 1.82
EXAC's PEG is ranked higher than
70% of the 70 Companies
in the Global Medical Devices industry.

( Industry Median: 3.32 vs. EXAC: 1.82 )
Ranked among companies with meaningful PEG only.
EXAC' s PEG Range Over the Past 10 Years
Min: 1.18  Med: 2.20 Max: 4.5
Current: 1.82
1.18
4.5
Shiller P/E 20.88
EXAC's Shiller P/E is ranked higher than
87% of the 67 Companies
in the Global Medical Devices industry.

( Industry Median: 33.18 vs. EXAC: 20.88 )
Ranked among companies with meaningful Shiller P/E only.
EXAC' s Shiller P/E Range Over the Past 10 Years
Min: 17.72  Med: 25.42 Max: 50.95
Current: 20.88
17.72
50.95
Current Ratio 5.54
EXAC's Current Ratio is ranked higher than
80% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.82 vs. EXAC: 5.54 )
Ranked among companies with meaningful Current Ratio only.
EXAC' s Current Ratio Range Over the Past 10 Years
Min: 1.64  Med: 4.47 Max: 8.45
Current: 5.54
1.64
8.45
Quick Ratio 2.79
EXAC's Quick Ratio is ranked higher than
62% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 2.04 vs. EXAC: 2.79 )
Ranked among companies with meaningful Quick Ratio only.
EXAC' s Quick Ratio Range Over the Past 10 Years
Min: 0.51  Med: 1.95 Max: 5.4
Current: 2.79
0.51
5.4
Days Inventory 359.24
EXAC's Days Inventory is ranked lower than
90% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. EXAC: 359.24 )
Ranked among companies with meaningful Days Inventory only.
EXAC' s Days Inventory Range Over the Past 10 Years
Min: 330.22  Med: 349.35 Max: 407.37
Current: 359.24
330.22
407.37
Days Sales Outstanding 75.71
EXAC's Days Sales Outstanding is ranked lower than
56% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 69.24 vs. EXAC: 75.71 )
Ranked among companies with meaningful Days Sales Outstanding only.
EXAC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.45  Med: 73.10 Max: 91
Current: 75.71
62.45
91
Days Payable 62.62
EXAC's Days Payable is ranked higher than
52% of the 255 Companies
in the Global Medical Devices industry.

( Industry Median: 60.71 vs. EXAC: 62.62 )
Ranked among companies with meaningful Days Payable only.
EXAC' s Days Payable Range Over the Past 10 Years
Min: 52.26  Med: 78.53 Max: 123.22
Current: 62.62
52.26
123.22

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 2.90
EXAC's Price/Net Current Asset Value is ranked higher than
83% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 6.29 vs. EXAC: 2.90 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
EXAC' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.87  Med: 4.76 Max: 18.45
Current: 2.9
1.87
18.45
Price/Tangible Book 1.40
EXAC's Price/Tangible Book is ranked higher than
87% of the 376 Companies
in the Global Medical Devices industry.

( Industry Median: 4.51 vs. EXAC: 1.40 )
Ranked among companies with meaningful Price/Tangible Book only.
EXAC' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.26  Med: 2.11 Max: 4.71
Current: 1.4
1.26
4.71
Price/Projected FCF 1.45
EXAC's Price/Projected FCF is ranked higher than
64% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. EXAC: 1.45 )
Ranked among companies with meaningful Price/Projected FCF only.
EXAC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.25  Med: 3.28 Max: 383
Current: 1.45
0.25
383
Price/DCF (Earnings Based) 1.48
EXAC's Price/DCF (Earnings Based) is ranked higher than
63% of the 41 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. EXAC: 1.48 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.88
EXAC's Price/Median PS Value is ranked higher than
62% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. EXAC: 0.88 )
Ranked among companies with meaningful Price/Median PS Value only.
EXAC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.71  Med: 1.33 Max: 2.59
Current: 0.88
0.71
2.59
Price/Peter Lynch Fair Value 2.22
EXAC's Price/Peter Lynch Fair Value is ranked higher than
57% of the 69 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. EXAC: 2.22 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
EXAC' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.65  Med: 1.96 Max: 4.41
Current: 2.22
0.65
4.41
Price/Graham Number 1.03
EXAC's Price/Graham Number is ranked higher than
79% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. EXAC: 1.03 )
Ranked among companies with meaningful Price/Graham Number only.
EXAC' s Price/Graham Number Range Over the Past 10 Years
Min: 0.91  Med: 1.44 Max: 2.67
Current: 1.03
0.91
2.67
Earnings Yield (Greenblatt) (%) 8.35
EXAC's Earnings Yield (Greenblatt) (%) is ranked higher than
86% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.90 vs. EXAC: 8.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
EXAC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.6  Med: 6.90 Max: 10.8
Current: 8.35
4.6
10.8
Forward Rate of Return (Yacktman) (%) 8.20
EXAC's Forward Rate of Return (Yacktman) (%) is ranked higher than
61% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. EXAC: 8.20 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
EXAC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 2.9  Med: 10.20 Max: 15
Current: 8.2
2.9
15

More Statistics

Revenue(Mil) $242
EPS $ 1.11
Beta1.24
Short Percentage of Float2.75%
52-Week Range $16.11 - 26.20
Shares Outstanding(Mil)14.08

Analyst Estimate

Dec15 Dec16 Dec17 Dec18
Revenue(Mil) 240 245 255 267
EPS($) 1.07 1.15 1.24 1.40
EPS without NRI($) 1.07 1.15 1.24 1.40

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Exactech Inc was founded by an orthopaedic surgeon in November 1985, and is incorporated under the laws of the State of Florida. The Company develops, manufactures, markets, distributes and sella orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its U.S. sales and distribution activities are conducted by its wholly owned subsidiary Exactech U.S., Inc. The Companys international development, sales and distribution activities are conducted by its wholly owned subsidiary Exactech International Operations, AG based in Bern, Switzerland. The Company manufactures some components of its knee, extremity, and hip joint replacement systems at its facility in Gainesville, Florida, utilizing modern, highly automated computer aided manufacturing equipment. Its cellular based manufacturing processes, which are organized in groups, or cells, are dedicated to specific product lines to minimize change-over and increase efficiency. To supplement its manufacturing of components, the company has formed strategic alliances with suppliers and business partners to externally manufacture some components. Additionally, the company acquires and distribute other products and services through exclusive agreements, such as its agreement with Tecres S.p.A, (Tecres) and Blue Ortho, SAS (Blue Ortho), and non-exclusive agreements, such as with RTI Surgical, Inc., (RTI), and Biomatlante SARL, (Biomatlante). The company markets its orthopaedic implant products in the United States through Exactech U.S., Inc. that operates through a network of independent sales agencies and direct sales representatives. The company offers its products in all fifty states, Puerto Rico, and the District of Columbia. The Companys competitors in the orthopaedic market are DePuy, Inc., a division of Johnson and Johnson, Zimmer, Inc., a subsidiary of Zimmer Holdings, Inc., Stryker Corporation, Smith and Nephew plc, and Biomet, Inc. The Companys operations are subject to numerous and increasingly stringent federal, state and local environmental laws and regulations in the United States and other countries in which they operates.
» More Articles for EXAC

Headlines

Articles On GuruFocus.com

More From Other Websites
Exactech Schedules Fourth Quarter and Year End 2015 Earnings Release and Conference Call Feb 05 2016
3 Reasons Why Exactech (EXAC) is a Great Value Stock Feb 02 2016
Exactech Acquires Australian Distributor Feb 01 2016
Exactech Acquires Australian Distributor Feb 01 2016
Exactech Stock: What is the Social Media Crowd Thinking About EXAC? Jan 27 2016
Zacks Investment Ideas feature highlights: Intuitive Surgical, Abiomed, Exactech and Iradimed Jan 26 2016
4 Medical Instrument Makers to Save Your Portfolio Jan 25 2016
Strength Seen in Nevro (NVRO): Stock Jumps 5.9% in Session Jan 12 2016
Exactech Announces the Sale of Its Dental Biologic Assets to Salvin Dental Specialties Jan 04 2016
3 Reasons Value Stock Investors Will Love Exactech (EXAC) Dec 31 2015
EXACTECH INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an... Dec 18 2015
Exactech Announces Renewal of $150 Million Senior Secured Debt Credit Facility Dec 18 2015
Direction of Market Influences - Free Research Reports on Travelzoo, Vicor, Exactech and Sizmek Dec 18 2015
EXACTECH INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 10 2015
EXACTECH INC Financials Dec 08 2015
Exactech Announces Stock Repurchase Authorization Dec 07 2015
The Price Data Tells the Story - Research on Cascade Microtech, Franklin Covey, Addus Homecare and... Dec 07 2015
What Do Hedge Funds Think of Natural Gas Services Group, Inc. (NGS)? Nov 28 2015
Technical Insight on Equities in Limelight - Research on Cascade Microtech, Franklin Covey, Addus... Nov 27 2015
How Has Smart Money Been Trading Kandi Technolgies Corp. (KNDI)? Nov 25 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK